Thin Film Electronics (Thinfilm) has announced that it has entered into an agreement with a Fortune 500 pharmaceutical firm to create an NFC OpenSense platform for medical devices.
The partners aim to leverage Thinfilm's proprietary NFC technology as a means to improve patient adherence and enhance communication between patients and their caregivers.
The pharmaceutical partnership follows several important milestones achieved by Thinfilm in the second quarter of 2016.
Davor Sutija, Thinfilm's CEO, said, "Lack of compliance among patients is a critical issue globally, and industry leaders are looking for effective solutions." Davor added, "Our partnership with one of the world's leading pharma companies is focused on delivering such a solution by making medical devices smart. We are very excited about the role NFC OpenSense can play in helping doctors and other caregivers improve patient outcomes."